Jana Andrejewski1, Fabio De Marco2, Konstantin Willer2, Wolfgang Noichl2, Alex Gustschin2, Thomas Koehler3, Pascal Meyer4, Fabian Kriner5, Florian Fischer5, Christian Braun5, Alexander A Fingerle6, Julia Herzen2, Franz Pfeiffer2,6, Daniela Pfeiffer6. 1. Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany. jana.andrejewski@tum.de. 2. Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany. 3. Philips Research, 22335, Hamburg, Germany. 4. Institute of Microstructure Technology, Karlsruhe Institute of Technology, 76344, Eggenstein-Leopoldshafen, Germany. 5. Institut für Rechtsmedizin, Ludwig-Maximilians-Universität München, 80336, Munich, Germany. 6. Department of Diagnostic and Interventional Radiology, Technical University of Munich, 81675, Munich, Germany.
Abstract
BACKGROUND: Grating-based x-ray dark-field and phase-contrast imaging allow extracting information about refraction and small-angle scatter, beyond conventional attenuation. A step towards clinical translation has recently been achieved, allowing further investigation on humans. METHODS: After the ethics committee approval, we scanned the full body of a human cadaver in anterior-posterior orientation. Six measurements were stitched together to form the whole-body image. All radiographs were taken at a three-grating large-object x-ray dark-field scanner, each lasting about 40 s. Signal intensities of different anatomical regions were assessed. The magnitude of visibility reduction caused by beam hardening instead of small-angle scatter was analysed using different phantom materials. Maximal effective dose was 0.3 mSv for the abdomen. RESULTS: Combined attenuation and dark-field radiography are technically possible throughout a whole human body. High signal levels were found in several bony structures, foreign materials, and the lung. Signal levels were 0.25 ± 0.13 (mean ± standard deviation) for the lungs, 0.08 ± 0.06 for the bones, 0.023 ± 0.019 for soft tissue, and 0.30 ± 0.02 for an antibiotic bead chain. We found that phantom materials, which do not produce small-angle scatter, can generate a strong visibility reduction signal. CONCLUSION: We acquired a whole-body x-ray dark-field radiograph of a human body in few minutes with an effective dose in a clinical acceptable range. Our findings suggest that the observed visibility reduction in the bone and metal is dominated by beam hardening and that the true dark-field signal in the lung is therefore much higher than that of the bone.
BACKGROUND: Grating-based x-ray dark-field and phase-contrast imaging allow extracting information about refraction and small-angle scatter, beyond conventional attenuation. A step towards clinical translation has recently been achieved, allowing further investigation on humans. METHODS: After the ethics committee approval, we scanned the full body of a human cadaver in anterior-posterior orientation. Six measurements were stitched together to form the whole-body image. All radiographs were taken at a three-grating large-object x-ray dark-field scanner, each lasting about 40 s. Signal intensities of different anatomical regions were assessed. The magnitude of visibility reduction caused by beam hardening instead of small-angle scatter was analysed using different phantom materials. Maximal effective dose was 0.3 mSv for the abdomen. RESULTS: Combined attenuation and dark-field radiography are technically possible throughout a whole human body. High signal levels were found in several bony structures, foreign materials, and the lung. Signal levels were 0.25 ± 0.13 (mean ± standard deviation) for the lungs, 0.08 ± 0.06 for the bones, 0.023 ± 0.019 for soft tissue, and 0.30 ± 0.02 for an antibiotic bead chain. We found that phantom materials, which do not produce small-angle scatter, can generate a strong visibility reduction signal. CONCLUSION: We acquired a whole-body x-ray dark-field radiograph of a human body in few minutes with an effective dose in a clinical acceptable range. Our findings suggest that the observed visibility reduction in the bone and metal is dominated by beam hardening and that the true dark-field signal in the lung is therefore much higher than that of the bone.
Entities:
Keywords:
Dark-field imaging; Human body; Radiography; Whole-body imaging; X-rays
Authors: Felix G Meinel; Andre Yaroshenko; Katharina Hellbach; Martin Bech; Mark Müller; Astrid Velroyen; Fabian Bamberg; Oliver Eickelberg; Konstantin Nikolaou; Maximilian F Reiser; Franz Pfeiffer; Ali Ö Yildirim Journal: Invest Radiol Date: 2014-10 Impact factor: 6.016
Authors: Thomas Baum; Elena Eggl; Andreas Malecki; Florian Schaff; Guillaume Potdevin; Olga Gordijenko; Eduardo Grande Garcia; Rainer Burgkart; Ernst J Rummeny; Peter B Noël; Jan S Bauer; Franz Pfeiffer Journal: J Comput Assist Tomogr Date: 2015 Mar-Apr Impact factor: 1.826
Authors: F Horn; K Gelse; S Jabari; C Hauke; S Kaeppler; V Ludwig; P Meyer; T Michel; J Mohr; G Pelzer; J Rieger; C Riess; M Seifert; G Anton Journal: Phys Med Biol Date: 2017-08-01 Impact factor: 3.609
Authors: Thomas Rauch; Jens Rieger; Georg Pelzer; Florian Horn; Ramona Erber; Marius Wunderle; Julius Emons; Naiba Nabieva; Nicole Fuhrich; Thilo Michel; Arndt Hartmann; Peter A Fasching; Gisela Anton Journal: Med Phys Date: 2020-02-21 Impact factor: 4.071
Authors: Thilo Michel; Jens Rieger; Gisela Anton; Florian Bayer; Matthias W Beckmann; Jürgen Durst; Peter A Fasching; Wilhelm Haas; Arndt Hartmann; Georg Pelzer; Marcus Radicke; Claudia Rauh; André Ritter; Peter Sievers; Rüdiger Schulz-Wendtland; Michael Uder; David L Wachter; Thomas Weber; Evelyn Wenkel; Andrea Zang Journal: Phys Med Biol Date: 2013-04-03 Impact factor: 3.609
Authors: Felix G Meinel; Felix Schwab; Simone Schleede; Martin Bech; Julia Herzen; Klaus Achterhold; Sigrid Auweter; Fabian Bamberg; Ali Ö Yildirim; Alexander Bohla; Oliver Eickelberg; Rod Loewen; Martin Gifford; Ronald Ruth; Maximilian F Reiser; Franz Pfeiffer; Konstantin Nikolaou Journal: PLoS One Date: 2013-03-26 Impact factor: 3.240
Authors: Konstantin Willer; Alexander A Fingerle; Lukas B Gromann; Fabio De Marco; Julia Herzen; Klaus Achterhold; Bernhard Gleich; Daniela Muenzel; Kai Scherer; Martin Renz; Bernhard Renger; Felix Kopp; Fabian Kriner; Florian Fischer; Christian Braun; Sigrid Auweter; Katharina Hellbach; Maximilian F Reiser; Tobias Schroeter; Juergen Mohr; Andre Yaroshenko; Hanns-Ingo Maack; Thomas Pralow; Hendrik van der Heijden; Roland Proksa; Thomas Koehler; Nataly Wieberneit; Karsten Rindt; Ernst J Rummeny; Franz Pfeiffer; Peter B Noël Journal: PLoS One Date: 2018-09-27 Impact factor: 3.240
Authors: Fabio De Marco; Konstantin Willer; Lukas B Gromann; Jana Andrejewski; Katharina Hellbach; Andrea Bähr; Michaela Dmochewitz; Thomas Koehler; Hanns-Ingo Maack; Franz Pfeiffer; Julia Herzen Journal: PLoS One Date: 2019-06-03 Impact factor: 3.240
Authors: Andre Yaroshenko; Katharina Hellbach; Ali Önder Yildirim; Thomas M Conlon; Isis Enlil Fernandez; Martin Bech; Astrid Velroyen; Felix G Meinel; Sigrid Auweter; Maximilian Reiser; Oliver Eickelberg; Franz Pfeiffer Journal: Sci Rep Date: 2015-12-01 Impact factor: 4.379
Authors: Elena Eggl; Susanne Grandl; Anikό Sztrόkay-Gaul; Martin Dierolf; Christoph Jud; Lisa Heck; Karin Burger; Benedikt Günther; Klaus Achterhold; Doris Mayr; Jan J Wilkens; Sigrid D Auweter; Bernhard Gleich; Karin Hellerhoff; Maximilian F Reiser; Franz Pfeiffer; Julia Herzen Journal: Sci Rep Date: 2018-10-24 Impact factor: 4.379